Daimuron

Daimuron

SCHEMBL1860112

Cc1ccc(NC(=O)NC(C)(C)c2ccccc2)cc1.Cc1ccc(NC(=O)NC(C)(C)c2ccccc2)cc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
MAPT P10636 4/20 0.51
ALDH1A1 P00352 5/20 0.51
LMNA P02545 3/20 0.51
CCR6 P51684 1/20 0.51
F7 P08709 1/20 0.51
MEN1 O00255 1/20 0.49
TP53 P04637 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
CASR P41180 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Daimuron SCHEMBL65275 1.00 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL7904977 0.92 RAB9A (0.52) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL2607688 0.91 RAB9A (0.50) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL8709318 0.90 SMN1; SMN2 (0.57) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL18079667 0.87 LMNA (0.53) MAPTALDH1A1LMNA
SCHEMBL8606898 0.83 HSD17B10 (0.53) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL28317115 0.82 F7 (0.53) MAPTALDH1A1LMNAF7
SCHEMBL16624883 0.82 MAPT (0.63) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL2607504 0.82 MAPT (0.73) NPC1RAB9AMAPTALDH1A1LMNA
Daimuron SCHEMBL9434861 0.81 NPC1 (0.46) NPC1RAB9ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237644-A1 OIL FLOWABLE APYRASE INHIBITOR FORMULATION TEXAS CROP SCIENCE, INC. 2024-07-18 US disclosed
US-20240156091-A1 WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION TEXAS CROP SCIENCE, INC. 2024-05-16 US disclosed
US-20240156090-A1 SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION TEXAS CROP SCIENCE, INC. 2024-05-16 US disclosed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed
US-20240101510-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed
EP-4338593-A1 AGRICULTURAL AND HORTICULTURAL FUNGICIDAL COMPOSITION Nippon Soda Co., Ltd. (JP) 2024-03-20 EP disclosed
WO-2024050040-A2 APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 WO disclosed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 WO disclosed
CN-116867373-A Herbicidal composition 日本曹达株式会社 2023-10-10 CN disclosed
US-10968492-B2 HPPD-inhibitor herbicide tolerance PIONEER HI-BRED INTERNATIONAL, INC. 2021-04-06 US disclosed
WO-1992013861-A1 HERBICIDAL BICYCLIC ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-20 WO disclosed
WO-1992009587-A1 HERBICIDAL OXAZINE ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-06-11 WO disclosed
WO-1992009578-A1 SUBSTITUTED FUSED HETEROCYCLIC HERBICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-06-11 WO disclosed
WO-1992004827-A1 HERBICIDAL SUBSTITUTED BICYCLIC TRIAZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-04-02 WO disclosed
EP-0463054-A1 SELECTIVE OXABICYCLOALKANES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-01-02 EP disclosed
WO-1991015478-A1 CROP-SELECTIVE HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-17 WO disclosed
WO-1991010668-A1 HERBICIDAL SULFONYLUREAS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-07-25 WO disclosed
WO-1991003464-A1 HERBICIDAL OXABICYCLO ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-03-21 WO disclosed
WO-1990012012-A1 SUBSTITUTED PHENYLTRIAZOLOPYRIMIDINE HERBICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-10-18 WO disclosed
WO-1990010634-A1 SELECTIVE OXABICYCLOALKANES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237644-A1 OIL FLOWABLE APYRASE INHIBITOR FORMULATION APEH, ACHE, ALOX5 NPC1 3244/4885RAB9A 2621/4885SMN1; SMN2 2890/4885
US-20240156090-A1 SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION APEH, DNPEP, ACHE NPC1 4654/4885RAB9A 2677/4885SMN1; SMN2 2119/4885
US-20240156091-A1 WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION CMA1, APEH, PM20D2 NPC1 2943/4885RAB9A 2053/4885SMN1; SMN2 4244/4885
US-20240101510-A1 APYRASE INHIBITORS APEH, DPEP1, PON1 NPC1 2564/4885RAB9A 1387/4885SMN1; SMN2 4511/4885
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP NPC1 3337/4885RAB9A 1777/4885SMN1; SMN2 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.